Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT07118618
PHASE2
Probenecid Administration for Alcohol Craving and Consumption
Sponsor: Brown University
View on ClinicalTrials.gov
Summary
This study proposes a 16-week, between-subject, double-blind, randomized controlled trial (RCT) with probenecid (2g /day) compared to placebo in individuals with AUD to test if reduces craving and alcohol consumption.
Official title: Probenecid, Pannexin 1 Channels for Alcohol Use Disorder
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2026-03-14
Completion Date
2030-12-31
Last Updated
2026-03-17
Healthy Volunteers
No
Interventions
DRUG
Probenecid Oral Tablet
2gr daily
DRUG
Placebo Oral Tablet
Inactive compound
Locations (1)
Brown University
Providence, Rhode Island, United States